NAD+ × FullScale Peptides — lab test, February 2026
COA 2602150266 matches freedomdiagnosticstesting.com's public record. So this test doesn't rest on our review alone — the lab confirms it too.
Full2602150266Test results
This is a purity and identity analysis. Sterility, endotoxins, and heavy metals were not screened — a high purity figure says nothing about those.
About this test
Label 500 mg · Lab measured 466.83 mg
93% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 116.7 mg using the measured mass, against 125 mg on the label — 7% less.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | 2602150266 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 6 Aug 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | freedomdiagnosticstesting.com's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of NAD+ from FullScale Peptides, performed by freedomdiagnosticstesting.com on February 17, 2026. Reported purity: 99.937%. Net content: 466.83 mg against 500 mg labeled (93% of label). Batch FSP-NAD500-0126-A. Sample source: shop-provided. Certificate of analysis attached.
Certificate of analysis
Have you tested this peptide?
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion